(Q39846686)

15 September 2017

1 reference

title

Pharmacokinetics, bioavailability and serum levels of cardiac glycosides (English)

1 reference

15 September 2017

0 references

1 reference

1 reference

T W Smith

1

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 May 1985

1 reference

Journal of the American College of Cardiology

15 September 2017

published in

1 reference

15 September 2017

volume

5

1 reference

15 September 2017

issue

5 Suppl A

1 reference

15 September 2017

page(s)

43A-50A

1 reference

Clinical pharmacokinetics of digitalis glycosides

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

1 reference

7 January 2021

Tritiated digoxin. XIX. Turnover studies in diabetes insipidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Renal tubular secretion of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Digoxin metabolism in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Administration of tritiated digoxin with and without a loading dose. A metabolic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Digoxin metabolism in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Digoxin disposition in obesity: Clinical pharmacokinetic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

A nomogram for digoxin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Absorption rates of some cardiac glycosides and portal blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Clinical Pharmacokinetics of Digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Binding of digitoxin and some related cardenolides to human plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Part I Digitalis glycosides: Mechanisms and manifestations of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Part II Digitalis glycosides: Mechanisms and manifestations of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Digitalis glycosides: mechanisms and manifestations of toxicity. Part III.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Effect of a pharmacologic dose of digoxin on inotropy in hyper- and normokalemic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Pharmacokinetic interactions between digoxin and other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Serum Digoxin Concentrations in the Human Fetus, Neonate and Infant

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Serum levels of digoxin in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Unusually large digitalis requirements. A study of altered digoxin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Interactions between digitoxin and other drugs in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Clinical pharmacokinetics of digitoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Bioavailability of drugs: the digoxin dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Absorption of Digoxin in Patients with Malabsorption Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Plasma Concentrations of Digoxin after Oral Administration in the Fasting and Postprandial State

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Altered absorption of digoxin in patients given propantheline and metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Editorial: Digoxin--the regulatory viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Human serum and myocardium digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Comparison of Serum Digoxin Level Measurement with Acetyl Strophanthidin Tolerance Testing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Factors affecting tolerance to digitalis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Digitalis intoxication. A prospective clinical study with serum level correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Plasma Digoxin Concentrations in Patients with Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980462-9

7 January 2021

10.1016/S0735-1097(85)80462-9

Identifiers

DOI

1 reference

15 September 2017

1 reference